Stockscreener 앱 받기
14.36
6.45%
-0.99
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
Is Rapport Therapeutics Inc. reversing from oversold territoryMarket Movement Recap & Safe Entry Momentum Tips - Newser
Best data tools to analyze Rapport Therapeutics Inc. stockWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - Newser
What moving averages say about Rapport Therapeutics Inc.Quarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
Short interest data insights for Rapport Therapeutics Inc.2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser
Is it time to cut losses on Rapport Therapeutics Inc.Trade Volume Summary & Weekly Stock Breakout Alerts - Newser
Evaluating Rapport Therapeutics Inc. with trendline analysisEarnings Recap Report & AI Driven Stock Price Forecasts - Newser
Real time breakdown of Rapport Therapeutics Inc. stock performancePortfolio Update Summary & Low Risk High Reward Trade Ideas - Newser
Ranking Rapport Therapeutics Inc. among high performing stocks via toolsJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
Short Interest Drops in Rapport Therapeutics Inc. After RallyJuly 2025 Reactions & Fast Momentum Stock Entry Tips - beatles.ru
Rapport Therapeutics to report phase 2a trial results for epilepsy drug - Investing.com Canada
Will Rapport Therapeutics Inc. benefit from AI trendsJuly 2025 Breakouts & High Accuracy Investment Signals - خودرو بانک
Can Rapport Therapeutics Inc. continue delivering strong returnsJuly 2025 Review & Daily Stock Momentum Reports - خودرو بانک
Rapport Therapeutics to report phase 2a trial results for epilepsy drug By Investing.com - Investing.com South Africa
Rapport Therapeutics To Report Epilepsy Trial Results On MondayWill The Stock Surge Or Tumble? - Nasdaq
Rapport Therapeutics' RAP-219: A Precision Medicine Play with High Stakes in September - AInvest
Earnings visualization tools for Rapport Therapeutics Inc.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
What hedge funds are buying Rapport Therapeutics Inc.Weekly Earnings Recap & Safe Entry Momentum Stock Tips - خودرو بانک
Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset - Seeking Alpha
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025 - The Manila Times
Rapport Therapeutics to Host Conference Call for Phase 2a Trial Topline Results of RAP-219 for Drug-Resistant Focal Onset Seizures - Quiver Quantitative
Rapport Therapeutics to Announce Topline Results for - GlobeNewswire
Key Epilepsy Drug Trial Results Coming Monday: Rapport's RAP-219 Phase 2a Data Could Impact Treatment - Stock Titan
Machine Learning Models Forecast Rapport Therapeutics Inc. UptickQuarterly Market Review & Risk Adjusted Swing Trade Ideas - beatles.ru
What is Rapport Therapeutics Inc. s 5 year growth outlookJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - خودرو بانک
Building trade automation scripts for Rapport Therapeutics Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Using RSI to spot recovery in Rapport Therapeutics Inc.2025 Sector Review & Accurate Entry/Exit Alerts - Newser
Measuring Rapport Therapeutics Inc.’s beta against major indicesJuly 2025 Reactions & Momentum Based Trading Ideas - Newser
Head-To-Head Analysis: Biofrontera (NASDAQ:BFRI) and Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Will Rapport Therapeutics Inc. outperform the marketWeekly Trend Summary & High Return Trade Opportunity Guides - Newser
Real time scanner hits for Rapport Therapeutics Inc. explainedQuarterly Trade Review & Risk Adjusted Buy/Sell Alerts - Newser
What data driven models say about Rapport Therapeutics Inc.’s futureMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
Rapport Therapeutics Inc. stock prediction for this weekMarket Sentiment Summary & Safe Entry Zone Tips - Newser
Analyzing Rapport Therapeutics Inc. with multi timeframe chartsMarket Growth Review & Detailed Earnings Play Strategies - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is Rapport Therapeutics Inc. stock poised for growthJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
Is this a good reentry point in Rapport Therapeutics Inc.July 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Analyzing drawdowns of Rapport Therapeutics Inc. with statistical toolsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Should you wait for a breakout in Rapport Therapeutics Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Rapport Therapeutics Inc. stock a value trap2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - khodrobank.com
How to monitor Rapport Therapeutics Inc. with trend dashboardsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
What’s the fair value of Rapport Therapeutics Inc. stockEarnings Overview Report & Weekly Top Gainers Alerts - خودرو بانک
Why Rapport Therapeutics Inc. is moving todayMarket Performance Report & Growth Focused Investment Plans - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
1.40%
자본화:
|
볼륨(24시간):